Drugging the catalytically inactive state of RET kinase in RET-rearranged tumors

Dennis Plenker(Cold Spring Harbor Laboratory), Martin L. Sos(German Cancer Research Center), Andreas H. Scheel(University of Cologne), Florian Mrugalla(TU Dortmund University), M Riedel(University of Cologne), Carina Lorenz(University of Cologne), Neil Q. McDonald(The Francis Crick Institute), Joachim Diebold(University of Lucerne), Yanrui Song(Crown Bioscience (China)), Marina Keul(TU Dortmund University), René P. Zahedi(Research Manitoba), Mike Bührmann(TU Dortmund University), Oliver Pagel(Leibniz Institute for Analytical Sciences - ISAS), Julian Engel(Research Complex at Harwell), Maarten Aerts(Ghent University), Johannes M. Heuckmann, André Richters(Massachusetts Institute of Technology), Marcel A. Dammert(University of Cologne), Roman K. Thomas(University of Cologne), Justina Stark(TU Dortmund University), Stefan M. Kast(TU Dortmund University), Martin Peifer(University of Cologne), Rakhee Chauhan(The Francis Crick Institute), Oliver Gautschi(Université Toulouse III - Paul Sabatier), Kris Gevaert(VIB-UGent Center for Medical Biotechnology), Georg Pall(University Hospital Innsbruck), Kevan M. Shokat(Howard Hughes Medical Institute), Johannes Brägelmann(University of Cologne), Reinhard Buettner(University of Cologne), Jürgen Wolf(University of Cologne), Phillip P. Knowles(The Francis Crick Institute), Frauke Leenders(Atotech (Germany)), Verena Tischler(University of Cologne), Daniel Schütte(University of Cologne), Yannic Alber(TU Dortmund University)
Science Translational Medicine
June 14, 2017
Cited by 64


Related Papers